Previous studies have suggested that CSF-1R mutation (e.g., G795A) in macrophages or IGF-1R/PI3K in PDG glioma cells contribute to resistance to CSF-1R inhibitors [19, 20]. This evidence concerns the gene CSF1R and glioma.